Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 2/2014

01-02-2014 | Research Article

Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer

Authors: Zhan-shan Wang, Yang Shen, Xu Li, Chong-zhi Zhou, Yu-gang Wen, Yu-biao Jin, Ji-kun Li

Published in: Tumor Biology | Issue 2/2014

Login to get access

Abstract

Abnormal activation of the hedgehog (Hh) signaling pathway has been found to be involved in the occurrence, invasion, and metastasis of cancers. Epithelial–mesenchymal transition (EMT) also plays an important role in the invasion and metastasis of cancers. However, the significance of the Hh signaling pathway and EMT in the invasion and metastasis of gastric cancer is still unclear. This study aimed to investigate the significance and prognostic value of the Hh signaling pathway and EMT in progressive gastric cancer. Immunohistochemistry was performed to detect the expression of the Hh-induced transcriptional factor Gli-1 and the EMT-related molecules Snail and E-cadherin in 121 patients with progressive gastric cancer. Histological type, depth of invasion, lymph node metastasis, and pTNM stage were also recorded. In progressive gastric cancer, Gli-1 expression increased markedly, and was closely associated with increased Snail expression and decreased E-cadherin expression. Diffuse type cancer, lymph node metastasis, and abnormal expression of E-cadherin were independent factors influencing the prognosis of patients with progressive gastric cancer. These findings suggest that abnormal activation of the Hh signaling pathway is closely related to the presence of EMT and is an important factor influencing the prognosis of patients with diffuse progressive gastric cancer.
Literature
1.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
2.
Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei W, Qiao Y, et al. Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol. 2011;17:4421–8.PubMedCrossRef
3.
Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007;10:75–83.PubMedCrossRef
4.
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29.PubMedCrossRef
5.
Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432(7015):324–31.PubMedCrossRef
6.
Wicking C, Smyt HI, Bale A. The hedgehog signaling pathway in tumorigenesis and development. Oncogene. 1999;18(55):7844–51.PubMedCrossRef
7.
Yoo YA, Kang MH, Kim JS, Oh C. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Carcinogenesis. 2008;29(3):480–90.PubMedCrossRef
8.
Thiery JP. Epithelial−mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.PubMedCrossRef
9.
Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, et al. Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression. J Cell Physiol. 2007;213(2):374–83.PubMedCrossRef
10.
Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 2006;66:11271–8.PubMedCrossRef
11.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. Chicago: Springer; 2010. p. 117–26.
12.
Ohno T, Aihara R, Kamiyama Y, Mochiki E, Asao T, Kuwano H. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer. Eur J Cancer. 2006;42(2):256–63.PubMedCrossRef
13.
Yoshikawa R, Nakano Y, Tao L, Koishi K, Matsumoto T, Sasako M, et al. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. Br J Cancer. 2008;98:1670–4.PubMedCentralPubMedCrossRef
14.
Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, et al. Differential expression of the epithelial−mesenchymal transition regulators snail, SIP-1, and twist in gastric cancer. Am J Pathol. 2002;161(5):1881–91.PubMedCrossRef
15.
Dessaud E, McMahon AP, Briscoe J. Pattern formation in the vertebrate neural tube: a sonic hedgehog morphogen-regulated transcriptional network. Development. 2008;135(15):2489–503.PubMedCrossRef
16.
17.
Katoh Y, Katoh M. Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther. 2005;4:1050–4.PubMedCrossRef
18.
Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, et al. Frequent activation of the hedgehog pathway in advanced gastric adenocardinomas. Carcinogenesis. 2005;26:1698–705.PubMedCrossRef
19.
Kim JY, Ko GH, Lee YJ, Ha WS, Choi SK, Jung EJ, et al. Prognostic value of hedgehog protein expression in gastric cancer. Jpn J Clin Oncol. 2012;42:1054–9.PubMedCrossRef
20.
Kamikihara T, Ishigami S, Arigami T, Matsumoto M, Okumura H, Uchikado Y, et al. Clinical implications of N-cadherin expression in gastric cancer. Pathol Int. 2012;62:161–6.PubMedCrossRef
21.
Ohta H, Aoyagi K, Fukaya M, Danjoh I, Ohta A, Isohata N, et al. Cross talk between hedgehog and epithelial−mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer. 2009;100:389–98.PubMedCentralPubMedCrossRef
22.
Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK, Kim HK, et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MM-9 pathway in gastric cancer. Cancer Res. 2011;71:7061–70.PubMedCrossRef
23.
Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial−mesenchymal transition-related protein expression in gastric carcinoma. Histopathology. 2009;54(4):442–51.PubMedCrossRef
24.
Katoh Y, Katoh M. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review). Int J Mol Med. 2008;22(3):271–5. Review.PubMed
25.
Katoh M. Epithelial−mesenchymal transition in gastric cancer. Int J Oncol. 2005;27:1677–83.PubMed
26.
Matsumura T, Makino R, Mitamura K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progress of hepatocellular carcinomas. Clin Cancer Res. 2001;7(3):594–9.PubMed
27.
Saze Z, Terashima M, Kogure M, Ohsuka F, Suzuki H, Gotoh M. Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer. Dig Surg. 2012;29(2):115–23.PubMedCrossRef
28.
Wei L, Xu Z. Cross-signaling among phosphoinositide 3-kinase, mitogen-activated protein kinase and sonic hedgehog pathways in esophageal cancer. Int J Cancer. 2011;129:275–84.PubMedCrossRef
Metadata
Title
Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer
Authors
Zhan-shan Wang
Yang Shen
Xu Li
Chong-zhi Zhou
Yu-gang Wen
Yu-biao Jin
Ji-kun Li
Publication date
01-02-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 2/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1185-1

Other articles of this Issue 2/2014

Tumor Biology 2/2014 Go to the issue

Research Article

The prognostic value of elevated ezrin in patients with osteosarcoma

Research Article

Diagnostic relevance of plasma DNA and DNA integrity for breast cancer

Research Article

Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis

Research Article

Prognostic significance of VEGF-C immunohistochemical expression in breast cancer: a meta-analysis

Review

The association between HIF-1α polymorphism and cancer risk: a systematic review and meta-analysis

Research Article

Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits